Vaginal yeast infections may occur more commonly during pregnancy, and most are treated with topical medications, or creams. Oral medications are prescribed when topical treatment fails, but the safety of such agents during pregnancy is controversial. A recent review and analysis published in the International Journal of Gynecology & Obstetrics examined all relevant studies published on this topic.
Vaginal yeast infections may occur more commonly during pregnancy, and most are treated with topical medications, or creams. Oral medications are prescribed when topical treatment fails, but the safety of such agents during pregnancy is controversial. A recent review and analysis examined all relevant studies published on this topic.
The analysis, which is published in the International Journal of Gynecology & Obstetrics, included eight cohort studies and one case-control study. The oral agents used during pregnancy were fluconazole and itraconazole.
Results indicated that oral fluconazole use during pregnancy might slightly increase the risk of congenital heart defects and limb defects relative to the general population, and oral itraconazole use during pregnancy might increase the risk of eye defects. No difference was found between oral fluconazole/itraconazole exposure and non-exposure in the risk of other birth defects, spontaneous abortion, or stillbirth.
“The meta-analysis found that the administration of fluconazole or itraconazole during pregnancy was not associated with an increased risk of overall birth defects, but it was associated with a possible increase in the risk of specific birth defects,” the authors wrote.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/ijgo.12993
About Journal
The International Journal of Gynecology & Obstetrics publishes articles on all aspects of basic and clinical research in the fields of obstetrics and gynecology and related subjects, with emphasis on matters of worldwide interest.
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com